Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease
Home | Video pages | Webcast | How intestinal microbiota can affect CKD-MBD: skeletal actions of PTH
Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease
Approaching the patient with CKD and comorbidities associated: how to choose the right treatment?